7th Annual Translational Microbiome Conference Washington

7th Annual Translational Microbiome Conference Washington is dedicated to the potential for translational interventions in microbiome research. The following therapeutic areas of research will be discussed:

• Obesity and Type 2 diabetes
• Women`s Health
• Immunology and the Impact of C. diffiicle Infections
• Pulmonology and COPD
• Periodontal Disease
• Dermatology

7th Annual Translational Microbiome Conference Washington covers topics such as:

• The applicability of animal microbiome models to the human microbiome
• The need for standardization and harmonization of research protocols
• How the FDA will and should regulate therapeutics containing live spores
• The business model for microbiome based therapeutics
• Data needs across multiple domains

7th Annual Translational Microbiome Conference Washington brings together Directors, VPs, Scientists, Heads and Professors from biotech companies, Academic Institutions, venture capitalists and pharma companies involved in:

• NGS (Next Generation Sequencing)
• Microbiome / Microbiota basic research
• Autoimmune Disease Therapeutics
• Molecular Diagnostics
• Metabolic disease, Obesity, Diabetes
• Infectious Diseases
• Genomics
• Genotyping
• Biomarkers
• Genomic Profiling
• Bioinformatics
• Immunology Innate or Adaptive Immunity
• Data Analysis
• Data Management
• Diagnostic & Clinical Applications
• Molecular Biology
• Vaccines
• Prenantal Diagnostics
• Food / Nutrition Science
• Microbiology
• Venture Capitalists
• Gut-Brain Axis Researchers
• Academic Licensing or Tech Transfer Officers
• Biotech Entrepreneurs

7th Annual Translational Microbiome Conference Washington will be held in Arlington, VA, United States on 26-27 Apr 2021.